gevokizumab,nivolumab,capecitabine,trifluridine tipiracil
xoma corporation,bms,taiho pharma,novartis
[]
circulating dna post adjuvant therapy in colorectal cancer . what to do ? clinical trials are on going .it is prognostic but clinical utility is subject to these trial results in future. #ascogi23 #gi23 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists